Join BOPA
Back to news articles

REGISTER NOW: #BOPA2024 Annual Conference @ICC Birmingham and AGM 2024

By BOPA on 5th April 2024

The 27th British Oncology Pharmacy Association (BOPA) Annual Conference, 11-13 October 2024, ICC Birmingham

 

We are pleased to announced that the registration for the BOPA Annual Conference 2024 is now open.

The BOPA Annual General Meeting (AGM) 2024 is also scheduled to be held on Saturday 12th October, 2024.

 

We recognise that NHS budgets are tighter than ever, so the committee have worked hard to give BOPA members a reduced conference fee of £300 (including VAT) if booked by Monday 16th September.

To register if you are a BOPA member:
https://media1.eventsair.com/the-27th-annual-bopa-conference-2024—members/birmingham

If you are not a BOPA member, please register via this link:
https://media1.eventsair.com/the-27th-annual-bopa-conference-2024—non-members/birmingham

 

DRAFT AGENDA can be downloaded HERE.

Specially negotiated rates at selected hotels are available for a limited period of time, for more information please click: https://www.bopa.org.uk/latest-conference-2024/.

 

We look forward to seeing you all in Birmingham. Keep an eye out for regular updates.
Follow #BOPA2024 on social media.

 

BOPA Conference committee with Media1 Productions

Latest News

By BOPA Research Committee on 27th April 2025

SURVEY: Understanding Clinicians’ perceptions of a Decision Support tool for Lung Cancer Treatment

Dear BOPA member, Tarini Deleep and Dr Pinkie Chambers from University College London are developing a risk prediction model to help identify patients with incurable Non Small Cell Lung Cancer,…

Read article
By BOPA on 27th April 2025

Further monographs for use of immunosuppressants in Immune-related adverse events (irAEs)

Earlier this year the BOPA Immunotherapy Group wrote, and published, four monographs to help health care professionals care for patients with immune-related adverse events. As a group we are pleased…

Read article
By BOPA Committee on 27th April 2025

Women for Oncology UK Spring Webinar

The Spring webinar for Women for Oncology UK is on the 16th May, to sign up click the link below. Women For Oncology UK Spring Webinar Tickets, Wed 14 May…

Read article
By BOPA Executive Committee on 25th April 2025

NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer at high risk of recurrence in adults.

BOPA have been involved with the following NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer…

Read article